Introduction
The development of experimental models of anxiety that readily translate between animals and humans is required to better integrate and clarify the biological, behavioural and cognitive mechanisms that underlie anxiety disorders and mediate response to treatment.
Inhalation of 7.5% CO 2 for 20 minutes increases self-report anxiety (e.g worry, tension) and autonomic arousal (e.g. heart rate, blood pressure), and provides a novel experimental model of generalized anxiety disorder (GAD) in healthy humans (Bailey et al 2005) that quantitatively and qualitatively differs from the established single vital capacity inhalation of 35% CO 2 model of panic (van den Hout and Griez, 1984, see Colasanti et al 2008 for detailed characterization of panic symptoms following 35% challenge in healthy volunteers). Evidence that acute benzodiazepine administration and chronic administration of selective serotonin reuptake inhibitors both attenuate subjective response to 7.5% challenge in healthy volunteers is consistent with their efficacy in patients with GAD, and further validates the 7.5% CO 2 model in humans (Bailey et al 2007) .
In rodents inhalation of 10% CO 2 triggers significant freezing behaviour, reduced activity in an open-field test and greater contextual fear conditioning, consistent with the anxiety phenotype (Ziemann et al 2009) . Recent evidence confirms the amygdala as an important 4 Garner et al. chemosensor that directly detects increases in CO 2 (via the acid-sensing ion-channel ASIC1a which is sensitive to localized reductions in pH) to elicit fear behaviour in mice (Ziemann et al 2009) .
Human neuro-cognitive models of anxiety propose a common amygdala-prefrontal circuitry that underlies fear-behaviour and dysfunctional cognitive processes that promote the detection and selection of threat, and increase distractibility to task-irrelevant information in anxiety (Bishop, 2007; Davis & Whalen, 2001; Davidson, 2002) .
Amygdala hyperactivity to threat has been observed in healthy individuals with high levels of state anxiety , high levels of generalized trait anxiety (Stein et al 2007) , and in patients with GAD (Nitschke et al 2009) and is strongly correlated with attention to threat in GAD (Monk et al 2008) .
Dysfunction in prefrontal cortex is observed when anxious individuals process threat distracters (Bishop et al 2004b) and lateral prefrontal cortex is implicated in mediating the modification of attentional bias to threat stimuli in healthy volunteers (Browning et al 2010) . Furthermore high levels of generalized trait anxiety are associated with reduced structural integrity in amgydala-prefrontal pathways (assessed using diffusion tensor imaging; Kim & Whalen, 2009) , and reduced (negative) functional connectivity between prefrontal cortex and amygdala during threat processing (Monk et al 2008;  for discussion of dysfunction in additional structures e.g. insula, see Paulus & Stein, 2006; Stein et al 2007) .
5 Garner et al. Together these findings are consistent with cognitive models of anxiety which emphasize increased activation of threat-related representations and a failure to use controlled processing to regulate attention and emotion in the aetiology of anxiety (Eysenck et al 2007) , and with extensive behavioural evidence of increased attention to environmental threat in anxiety (review by Bar-Haim et al 2007) .
In the antisaccade task, top-down attention control is required to suppress (inhibit) reflexive saccades (eye-movements) toward abrupt peripheral visual stimuli and instead generate a volitional saccade in the opposite direction ('antisaccade'). Enhanced activity in prefrontal cortex (dorso-lateral and ventro-lateral) during (correct) antisaccade trials supports the involvement of these regions in regulating attention allocation by inhibiting reflexive attentional capture by distracters (Ettinger et al 2008) . Previous research with the antisaccade task has revealed deficits in attention control in individuals with high generalized trait anxiety (Garner et al 2009; Ansari et al 2008) .
While inhalation of low concentrations of CO 2 increase anxiety and autonomic arousal in humans and triggers fear behaviour coordinated by the amygdala in small rodents, its effects on human neurocognitive mechanisms considered to underlie anxiety (e.g. selective attention to threat) are not known. The present study therefore examined whether 7.5% CO 2 challenge (relative to normal air) increases attention towards and impairs inhibition of threat stimuli within a modified emotional variant of the antisaccade task.
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Materials and Methods

Participants
Twenty six healthy volunteers (12 females; mean age 21.3 years, SD = 3.0 years) were recruited from the local community. Participants attended a pre-test screening interview during which they underwent a short structured diagnostic interview based on DSM-IV criteria (Mini International Neuropsychiatric Interview -MINI; Sheehan et al 1998) .
Exclusion criteria included recent use of medication (past eight weeks bar local treatment, occasional aspirin or paracetamol, oral, injectable or skin patch contraception), pregnancy, history of asthma/respiratory illness, high blood pressure (> 140/90), cardiovascular disease, migraines, current or lifetime history of psychiatric illness (including lifetime history/family history of panic attacks), smoker, under-or overweight (body-mass index less than 18 or greater than 28), current or past drug or alcohol dependence and recent use of illicit drugs (urine screen) or alcohol (breath test).
Participant levels of generalized trait anxiety (Spielberger et al 1983: m = 34.8, SD = 7.2) and fear of anxiety sensations (anxiety sensitivity, Taylor and Cox, 1998; m = 14.3, SD = 6 .2) are indicative of those reported in healthy control samples.
Procedure
Participants attended a single test session in which they completed an emotional variant of the antisaccade task during twenty minute inhalation of 7.5% CO 2 and air. Gas was administrated blind to participants through an oro-nasal face mask with order of gas presentation counterbalanced across participants. Heart rate, diastolic and systolic blood Saccade direction and latency were scored manually and blind to trial-type and inhalation condition using AcqKnowledge software. Saccades with a latency less than 100 msec (i.e. reflecting anticipatory eye-movements = 2.1% of data) or that subtended less than 6 horizontal degrees (i.e. did not terminate in the location/mirror location of the picture = 0.8% of data) were removed from analyses. The amount of missing data did not vary across conditions. Saccade accuracy and latencies for correct saccades were entered into separate repeated measures analyses of variance (ANOVA) with inhalation (7.5% CO 2 vs. air), trial-type (pro vs. antisaccade), and image valence (negative vs. neutral) as independent variables.
Results
Inhalation of 7.5% CO 2 produced significant increases in anxiety, negative affect, blood pressure and heart rate and a significant decrease in positive affect compared to inhalation of air and pre-test baseline, see Table 1. 1 During each inhalation period participants also completed a short (5 minute) face classification task. This task addressed different research questions to those of the present study and results are to be reported elsewhere by different authors. Task-order was counter-balanced across participants and did not interact with/moderate the observed effects of CO 2 on eye-movements to threat, reported below (i.e. gas x trial type x image valence x task-order, F < 1, p = .98). 
Associations between self-report and autonomic response to CO 2 challenge and
antisaccade performance: Change scores were calculated to reflect the degree of CO 2 -induced increases in i) subjective (self-report state anxiety) and autonomic response, ii)
proportion of erroneous eye-movements towards negative vs. neutral stimuli on antisaccade trials, iii) time taken to correctly orient away from (i.e. inhibit) negative vs.
neutral stimuli on antisaccade trials and iv) speed to correctly orient towards negative vs.
neutral stimuli on prosaccade trials.
10 Garner et al. Increased heart rate following CO 2 inhalation (relative to baseline) was associated with increased state anxiety (relative to baseline, r = .44, p < .05) but neither measure was correlated with performance measures on the antisaccade task. Individual differences in trait anxiety and anxiety sensitivity were not associated with subjective or physiological response to CO 2 , nor antisaccade performance. 
Discussion
Our findings are the first to show that 7.5% CO 2 inhalation can trigger dysfunction in neurocognitive mechanisms that characterize generalized anxiety. Inhalation of 7.5% CO 2 induced erroneous eye-movements towards negative stimuli on antisaccade trials, consistent with evidence that patients with GAD more readily orient towards threat stimuli in other eye-tracking paradigms (Mogg et al 2000) .
CO 2 challenge substantially increased self-report anxiety and autonomic arousal, consistent with previous findings (Bailey et al 2005) , and revealed correlations between subjective (state anxiety) response to CO 2 and increases in heart rate, but not blood pressure (likely reflecting the greater interoceptive salience/awareness of heart rate when determining subjective levels of distress).
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Blood pressure response to challenge was strongly associated with CO 2 -induced deficits in threat inhibition (i.e. greater orienting towards and slower orienting away from threat on antisaccade trials); and was further associated with faster eye-movements towards threat on prosaccade trials. These associations reflect a large effect size and CO 2 -induced increases in blood pressure and selective attention to threat were of comparable magnitude (small-medium effect sizes). However their covariation could be further clarified by measuring autonomic response throughout the inhalation period (in addition to immediately afterwards as in our study).
The strong relationships between induced change in blood pressure and attention to threat remained significant after controlling for CO 2 induced change in state anxiety (which itself was not correlated with induced attention to threat). These findings demonstrate that inhalation of 7.5% CO 2 can induce hyper-vigilance towards and deficient inhibition of threat in humans independent of changes in subjective mood. 2 Future studies should clarify the extent to which 7.5% CO 2 modulates attention to threat independent of changes in subjective mood through direct comparison of CO 2 challenge with nonpharmacological mood induction procedures that can further control for subjective anxiety (such as Hayes et al. 2008 ; anticipatory worry period of the Trier social stress test, Kirschbaum et al. 1993) . Future evidence that 7.5% CO 2 and non-pharmacological stressors known to trigger characteristics associated with GAD (e.g worry, nervous apprehension) produce comparable subjective response profiles that differ from the effects of 35% CO 2 challenge, would lend further support to proposals that the 7.5% CO 2 challenge models GAD, rather than acute fear and panic.
Supplementary analyses confirmed that CO 2 -induced change in antisaccade performance was not affected by the duration of inhalation either prior to commencing, or during the antisaccade task. This is consistent with evidence that the autonomic effects of 7.5% CO 2 rise early in the inhalation period and then plateau with minor fluctuations (Poma et al. 2005; Bailey et al. 2005) . Studies have yet to examine variation in subjective effects during inhalation and it would be of interest to directly assess the temporal characteristics and covariation of subjective, autonomic (including respiration rate/volume) and neurocognitive processing of threat (and positive/neutral control stimuli) throughout the CO 2 inhalation period.
Our findings complement evidence that 10% CO 2 elicits anxious behaviour in rodents (Ziemann et al 2009) . Recent evidence that CO 2 triggers fear behaviour in rats via ASC1a in amygdala suggests a mechanism through which CO 2 can increase the salience of environmental threat cues, interrupt goal-directed behaviour and direct processing resources to threat through interactions with prefrontal cortex Davidson, 2002) and co-modulate autonomic response. Future research should clarify the extent to which CO 2 -induced threat processing in humans reflects amygdalic innervation of norepinephrine via the locus coeruleus [also subject to direct regulation by CO 2 14 Garner et al. (Pineda and Aghajanian 1997) and implicated in both response to CO 2 challenge (Bailey et al 2003) and attention (Grefkes et al 2010) ] and interactions with GABAergic mechanisms involved in response to CO 2 challenge and threat inhibition (Bailey and Nutt 2008) .
Our findings show clear effects of 7.5% CO 2 inhalation on selective attention to threat in healthy humans and further validate the CO 2 model as a promising unconditioned crossspecies translational tool with which to challenge (and evaluate novel treatments that aim to resolve) subjective, autonomic and neuro-cognitive processes that underlie anxious behaviour in humans, and that characterize the generalized anxiety phenotype. 
